Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03943342
Title Ibrutinib and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia After Ibrutinib Resistance
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kerry Rogers
Age Groups: adult | senior
Covered Countries

No variant requirements are available.